{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:45:53Z","timestamp":1783485953844,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.mce.2013.04.010","type":"journal-article","created":{"date-parts":[[2013,4,26]],"date-time":"2013-04-26T07:48:37Z","timestamp":1366962517000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["miRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy \u2013 Role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a\/\u03b1-MHC modulation"],"prefix":"10.1016","volume":"374","author":[{"given":"Gabriela Placon\u00e1","family":"Diniz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luiza Morais","family":"Barreto-Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2013.04.010_b0005","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00395-012-0278-0","article-title":"Role of miR-21 in the pathogenesis of atrial fibrosis","volume":"107","author":"Adam","year":"2012","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.mce.2013.04.010_b0010","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1590\/S0100-879X2000000600007","article-title":"Stimulatory effect of dexamethasone on angiotensin-converting enzyme in neonatal rat cardiac myocytes","volume":"33","author":"Barreto-Chaves","year":"2000","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.mce.2013.04.010_b0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.mce.2013.04.010_b0020","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nrg1328","article-title":"Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs","volume":"5","author":"Bartel","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.mce.2013.04.010_b0025","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1172\/JCI36154","article-title":"MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice","volume":"119","author":"Callis","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2013.04.010_b0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00395-010-0089-0","article-title":"Blockage of Angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation","volume":"105","author":"Carneiro-Ramos","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.mce.2013.04.010_b0040","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2353\/ajpath.2007.061170","article-title":"MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?","volume":"170","author":"Cheng","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2013.04.010_b0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10741-008-9125-7","article-title":"Cardiac hypertrophy and thyroid hormone signaling","volume":"15","author":"Dillmann","year":"2010","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.mce.2013.04.010_b0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00424-006-0192-0","article-title":"Angiotensin type 1 (AT1) and type 2 (AT2) receptors mediate the increase in TGF-beta1 in thyroid hormone-induced cardiac hypertrophy","volume":"454","author":"Diniz","year":"2007","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.mce.2013.04.010_b0055","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00395-009-0043-1","article-title":"Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt\/GSK-3beta\/mTOR signaling pathway","volume":"104","author":"Diniz","year":"2009","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.mce.2013.04.010_b0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/JME-11-0141","article-title":"New insight into the mechanisms associated with the rapid effect of T3 on AT1R expression","volume":"49","author":"Diniz","year":"2012","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.mce.2013.04.010_b0065","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/CIRCRESAHA.108.183087","article-title":"The emerging role of microRNAs in cardiac remodeling and heart failure","volume":"103","author":"Divakaran","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2013.04.010_b0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1210\/rp.59.1.31","article-title":"Effects of thyroid hormone on the cardiovascular system","volume":"59","author":"Fazio","year":"2004","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.mce.2013.04.010_b0075","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.yjmcc.2007.07.045","article-title":"Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure","volume":"43","author":"Gupta","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.mce.2013.04.010_b0080","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/ars.2007.1474","article-title":"Cardiac hypertrophy: mechanisms and therapeutic opportunities","volume":"9","author":"Gupta","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.mce.2013.04.010_b0085","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/0022-2828(95)90013-6","article-title":"Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction","volume":"27","author":"Hanatani","year":"1995","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.mce.2013.04.010_b0090","doi-asserted-by":"crossref","first-page":"R1473","DOI":"10.1152\/ajpregu.00269.2003","article-title":"Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling","volume":"285","author":"Hu","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.mce.2013.04.010_b0095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1073\/pnas.85.2.339","article-title":"Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload","volume":"85","author":"Izumo","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mce.2013.04.010_b0100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1476-5381.2011.01375.x","article-title":"Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes","volume":"164","author":"Jeppesen","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mce.2013.04.010_b0105","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/er.2003-0033","article-title":"Thyroid hormone action in the heart","volume":"26","author":"Kahaly","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2013.04.010_b0110","doi-asserted-by":"crossref","first-page":"20666","DOI":"10.1074\/jbc.M512671200","article-title":"Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways","volume":"281","author":"Kenessey","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2013.04.010_b0115","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system","volume":"344","author":"Klein","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2013.04.010_b0120","first-page":"H593","article-title":"Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism","volume":"273","author":"Kobori","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.mce.2013.04.010_b0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1677\/joe.0.1600043","article-title":"Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy","volume":"160","author":"Kobori","year":"1999","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.mce.2013.04.010_b0130","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1210\/en.2007-0099","article-title":"Rapamycin prevents thyroid hormone-induced cardiac hypertrophy","volume":"148","author":"Kuzman","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2013.04.010_b0135","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1073\/pnas.89.12.5251","article-title":"Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism","volume":"89","author":"Landenson","year":"1992","journal-title":"PNAS USA"},{"key":"10.1016\/j.mce.2013.04.010_b0140","doi-asserted-by":"crossref","first-page":"15073","DOI":"10.1074\/jbc.M207593200","article-title":"Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endothelin-dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes","volume":"278","author":"Liang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2013.04.010_b0145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/B:MCBI.0000028765.89855.73","article-title":"Renin-angiotensin blockade attenuates cardiac myofibrillar remodelling in chronic diabetes","volume":"261","author":"Machackova","year":"2004","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.mce.2013.04.010_b0160","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.111.030932","article-title":"Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure","volume":"124","author":"Montgomery","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2013.04.010_b0165","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1097-0029(20000915)50:6<522::AID-JEMT9>3.0.CO;2-U","article-title":"Control of cardiac myosin heavy chain gene expression","volume":"50","author":"Morkin","year":"2000","journal-title":"Microsc. Res. Technol."},{"key":"10.1016\/j.mce.2013.04.010_b0170","doi-asserted-by":"crossref","first-page":"958626","DOI":"10.4061\/2011\/958626","article-title":"Thyroid hormone and cardiac disease: from basic concepts to clinical application","volume":"2011","author":"Mourouzis","year":"2011","journal-title":"J. Thyroid Res."},{"key":"10.1016\/j.mce.2013.04.010_b0175","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1055\/s-2005-870317","article-title":"Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning","volume":"37","author":"Pantos","year":"2005","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.mce.2013.04.010_b0180","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2006.02.030","article-title":"Micro RNAs in animal development","volume":"124","author":"Plasterk","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.mce.2013.04.010_b0185","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/01.HYP.35.1.424","article-title":"High- or low-salt diet from weaning to adulthood: effect on insulin sensitivity in Wistar rats","volume":"35","author":"Prada","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2013.04.010_b0190","doi-asserted-by":"crossref","first-page":"654904","DOI":"10.1155\/2012\/654904","article-title":"Cardiac insulin resistance and microRNA modulators","volume":"2012","author":"Pulakat","year":"2012","journal-title":"Exp. Diab. Res."},{"key":"10.1016\/j.mce.2013.04.010_b0195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.RES.73.3.413","article-title":"Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype","volume":"73","author":"Sadoshima","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2013.04.010_b0200","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.RES.0000257913.42552.23","article-title":"MicroRNAs play an essential role in the development of cardiac hypertrophy","volume":"100","author":"Sayed","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2013.04.010_b0205","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pharmthera.2008.05.010","article-title":"Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks","volume":"119","author":"Schl\u00fcter","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.mce.2013.04.010_b0210","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.110.977066","article-title":"Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice","volume":"123","author":"Shende","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2013.04.010_b0215","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.yjmcc.2007.04.004","article-title":"Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy","volume":"42","author":"Tatsuguchi","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.mce.2013.04.010_b0220","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/CIRCULATIONAHA.107.687947","article-title":"MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure","volume":"116","author":"Thum","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2013.04.010_b0225","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/cvr\/cvn137","article-title":"MicroRNAs: novel regulators in cardiac development and disease","volume":"79","author":"Thum","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2013.04.010_b0230","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.mce.2013.04.010_b0235","doi-asserted-by":"crossref","first-page":"18255","DOI":"10.1073\/pnas.0608791103","article-title":"A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure","volume":"103","author":"van Rooij","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mce.2013.04.010_b0240","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1126\/science.1139089","article-title":"Control of stress-dependent cardiac growth and gene expression by a microRNA","volume":"316","author":"van Rooij","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.mce.2013.04.010_b0245","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/CIRCRESAHA.108.183426","article-title":"Toward microRNA-based therapeutics for heart disease: the sense in antisense","volume":"103","author":"van Rooij","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2013.04.010_b0250","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.devcel.2009.10.013","article-title":"A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance","volume":"17","author":"van Rooij","year":"2009","journal-title":"Dev. Cell."},{"key":"10.1016\/j.mce.2013.04.010_b0255","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/iub.204","article-title":"Role of microRNAs in cardiac hypertrophy and heart failure","volume":"61","author":"Wang","year":"2009","journal-title":"IUBMB Life"},{"key":"10.1016\/j.mce.2013.04.010_b0260","doi-asserted-by":"crossref","first-page":"H1997","DOI":"10.1152\/ajpheart.01106.2005","article-title":"Transcription factor CHF1\/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4","volume":"290","author":"Xiang","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030372071300155X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030372071300155X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T13:56:37Z","timestamp":1539698197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030372071300155X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":49,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S030372071300155X"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2013.04.010","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy \u2013 Role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a\/\u03b1-MHC modulation","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2013.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}